Is Cue Biopharma a good buy right now?
USNASDAQ: CUENASDAQ-listedlast $28.79 · 2 Jun 2026
Not yet — wait
Signal paused. CUE's price history has a jump — most likely a split or bonus issue that was not adjusted — and 12 trades touching it were left out until the data is checked. The last Buy signal came on 21 May 2026 at $18.95 and closed on 2 Jun 2026 (+51.9%).
As of 30 Sep 2026 · Firefly Breakout Weekly
What happened after the last 14 buy signals on CUE
Oct 2024 – 30 Sep 20262 of 14 closed above the entry price, with an average outcome of −7.0% per signal before costs; a signal typically stayed open about 1 d. 12 trades touching a jump in the price data were left out.
| Buy signal | Price then | Closed | Held | Outcome |
|---|---|---|---|---|
| 21 May 2026 | $18.95 | 2 Jun 2026 | 12 d | +51.9% |
| 28 Apr 2026 | $13.73 | 28 Apr 2026 | 1 d | -18.3% |
| 24 Apr 2026 | $18 | 24 Apr 2026 | 1 d | -22.6% |
| 23 Apr 2026 | $17.55 | 24 Apr 2026 | 1 d | -20.6% |
| 22 Apr 2026 | $18.89 | 22 Apr 2026 | 1 d | -21.4% |
| 20 Apr 2026 | $17.49 | 22 Apr 2026 | 2 d | -15.1% |
| 16 Apr 2026 | $19.75 | 16 Apr 2026 | 1 d | -15.6% |
| 15 Apr 2026 | $13.78 | 15 Apr 2026 | 1 d | +60.2% |
| 13 Apr 2026 | $14.13 | 13 Apr 2026 | 1 d | -15.0% |
| 21 Oct 2024 | $41.25 | 18 Nov 2024 | 4 wk | -22.9% |
| 11 Oct 2024 | $40.95 | 11 Oct 2024 | 1 d | -11.4% |
| 10 Oct 2024 | $42.45 | 10 Oct 2024 | 1 d | -13.1% |
| 8 Oct 2024 | $40.65 | 8 Oct 2024 | 1 d | -14.4% |
| 7 Oct 2024 | $43.2 | 7 Oct 2024 | 1 d | -20.1% |
Outcomes are simulated by applying Firefly's rules to historical prices, before costs and slippage. Sell triggers are not counted: Firefly reads them as “don't enter”, not as short trades. Past behaviour of a rule is not a prediction of future prices.
The strategy behind this page
one rule set per market · beta| Strategy | Horizon | Signal | Since | Buy signals closed higher |
|---|---|---|---|---|
| Firefly Breakout Weekly | Medium term | No signal | — | 14% |
This beta publishes one rule set per market — Firefly Breakout Weekly — chosen in the October 2026 review. What the beta shows and how the data was cleaned →
Same theme beyond US
same theme, other marketsIndian peers are listed on the NSE and priced in rupees. Crypto gains are taxed at 30% in India with 1% TDS. Shown for context — not a recommendation to switch markets.
More questions about CUE
CUE share price today — buy or sell?
As of 30 Sep 2026, Firefly Breakout Weekly says wait on Cue Biopharma. Signal paused. CUE's price history has a jump — most likely a split or bonus issue that was not adjusted — and 12 trades touching it were left out until the data is checked. The last Buy signal came on 21 May 2026 at $18.95 and closed on 2 Jun 2026 (+51.9%). The last price on record was $28.79 on 2 Jun 2026.
How has Firefly's strategy done on Cue Biopharma?
From October 2024 to 30 Sep 2026 Firefly's rules gave 14 buy signals on Cue Biopharma; 2 closed above the entry price and the average outcome was −7.0% per signal, simulated on historical prices before costs. A handful of signals is a pattern, not a statistic.
What is the Cue Biopharma price target?
We don't publish price targets — no rule-based system can forecast a price. Firefly Breakout Weekly closes each signal by its own rules; every closed signal on Cue Biopharma and how it turned out is listed on this page.
Should I sell Cue Biopharma?
No sell trigger is active on Cue Biopharma as of 30 Sep 2026. This describes a rule, not advice on your position.
Why does this page show a single strategy?
This is the Signals beta. Each market publishes one rule set — here Firefly Breakout Weekly — instead of a vote across Firefly's whole library, and the verdict is its signal as of 30 Sep 2026. Sell triggers count as “don't enter”; only buy triggers are scored.
Fintrens shows how one of Firefly's rule-based strategies reads this stock. It is educational information, not investment advice and not a recommendation to buy or sell. We do not publish price targets. Indian residents buy US stocks under the RBI's Liberalised Remittance Scheme; tax is collected at source above the annual threshold. Read how Firefly's strategies work →